Involvement of different types of potassium channels in the antidepressant-like effect of tramadol in the mouse forced swimming test

被引:17
作者
Jesse, Cristiano R. [1 ]
Wilhelm, Ethel A. [1 ]
Barbosa, Nilda B. V. [1 ]
Nogueira, Cristina W. [1 ]
机构
[1] Univ Fed Santa Maria, Lab Sintese Reatividade & Avaliacao Farmacol & To, Ctr Ciencias Nat & Exatas, BR-97105900 Santa Maria, RS, Brazil
关键词
Tramadol; Potassium channels; Antidepressant; Mice (Mouse); Forced swimming test; RECEPTOR-MEDIATED ACTIVATION; GUANYLATE-CYCLASE PATHWAY; RECTIFYING K+ CURRENT; 5-HT1B RECEPTORS; SMOOTH-MUSCLE; MICE; DEPRESSION; MODEL; 5-HYDROXYTRYPTAMINE; INHIBITION;
D O I
10.1016/j.ejphar.2009.04.041
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Administration of tramadol elicited an antidepressant-like effect in the rat forced swimming test (FST) by a mechanism dependent on the inhibition of the L-arginine-nitric oxide (NO)-guanylate cyclase pathway. Since it has been reported that NO can activate different types of potassium (K+) channels in several tissues, the present study investigated the possibility of synergistic interactions between different types of K+ channel inhibitors and tramadol in the mouse FST. Intracerebroventricular pretreatment of mice with tetraethylammonium (TEA, a non-specific inhibitor of K+ channels, 25 pg/site), glibenclamide (an ATP-sensitive K+ channel inhibitor, 0.5 pg/site) or charybdotoxin (a large- and intermediate conductance calcium-activated K+ channel inhibitor, 25 pg/site) was able to produce a synergistic action of a subeffective dose of tramadol (1 mg/kg, p.o.). Conversely, pretreatment with apamin (a small-conductance calcium-activated K+ channel inhibitor, 10 pg/site) did not modify the action of a subeffective dose of tramadol (1 mg/kg, p.o.). Administration of tramadol and the K+ channel inhibitors, alone or in combination, did not affect the number of crossings and rearings in the open field test (OFT). Reduction in the immobility time elicited by an active dose of tramadol (40 mg/kg, p.o.) in the FST was prevented by pretreatment of mice with cromakalim (a K+ channel opener, 10 pg/site, i.c.v.), without affecting the number of crossings and rearings in the OFT. Thus, our findings clearly suggest that oral acute administration of tramadol produces antidepressant-like effect on the FST in mice by a mechanism that involves the K+ channels. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:74 / 78
页数:5
相关论文
共 36 条
[1]   A-G PROTEIN COUPLES SEROTONIN AND GABA-B RECEPTORS TO THE SAME CHANNELS IN HIPPOCAMPUS [J].
ANDRADE, R ;
MALENKA, RC ;
NICOLL, RA .
SCIENCE, 1986, 234 (4781) :1261-1265
[2]   Differential role of 5-HT1A and 5-HT1B receptors on the antinociceptive and antidepressant effect of tramadol in mice [J].
Berrocoso, Esther ;
Rojas-Corrales, M. Olga ;
Mico, Juan A. .
PSYCHOPHARMACOLOGY, 2006, 188 (01) :111-118
[3]   NITRIC-OXIDE DIRECTLY ACTIVATES CALCIUM-DEPENDENT POTASSIUM CHANNELS IN VASCULAR SMOOTH-MUSCLE [J].
BOLOTINA, VM ;
NAJIBI, S ;
PALACINO, JJ ;
PAGANO, PJ ;
COHEN, RA .
NATURE, 1994, 368 (6474) :850-853
[4]  
BORSINI F, 1988, PSYCHOPHARMACOLOGY, V94, P147
[5]   Role of different types of potassium channels in the antidepressant-like effect of agmatine in the mouse forced swimming test [J].
Budni, Josiane ;
Gadotti, Vinicius M. ;
Kaster, Manuella P. ;
Santos, Adair R. S. ;
Rodrigues, Ana Lucia S. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 575 (1-3) :87-93
[6]   Assessing antidepressant activity in rodents: recent developments and future needs [J].
Cryan, JF ;
Markou, A ;
Lucki, I .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (05) :238-245
[7]   INTERACTION OF THE CENTRAL ANALGESIC, TRAMADOL, WITH THE UPTAKE AND RELEASE OF 5-HYDROXYTRYPTAMINE IN THE RAT-BRAIN INVITRO [J].
DRIESSEN, B ;
REIMANN, W .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (01) :147-151
[8]  
FUJINO K, 1991, J PHARMACOL EXP THER, V256, P371
[9]   Effect of potassium channel modulators in mouse forced swimming test [J].
Galeotti, N ;
Ghelardini, C ;
Caldari, B ;
Bartolini, A .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (07) :1653-1659
[10]  
HENNIES HH, 1988, ARZNEIMITTELFORSCH, V38-2, P877